Market Place
Sourcing Support
Editas Medicine And Genevant Collaborate On mRNA-LNP Therapeutics
21 Oct 2024 //
GLOBENEWSWIRE
Repair licenses Genevant`s tech for up to $107M per product
27 Sep 2024 //
FIERCE BIOTECH
Repair Biotechnologies And Genevant Sciences To Collaborate
26 Sep 2024 //
GLOBENEWSWIRE
Judge Rules Against Moderna in COVID-19 Patent Fight with Roivant Subsidiary
04 Apr 2024 //
BIOSPACE
Genevant Sciences to Collaborate with Tome Biosciences
16 Jan 2024 //
GLOBENEWSWIRE
Genevant secures $114M deal with Tome to develop liver therapy
16 Jan 2024 //
FIERCE BIOTECH
Genevant Sciences to Collaborate with Novo Nordisk
06 Nov 2023 //
GLOBENEWSWIRE
Genevant Sciences LNP Technology Used in samRNA Covid-19 Vaccine Candidate
12 Oct 2023 //
GLOBENEWSWIRE
Gritstone bio and Genevant Sciences Announce Option and License Agreement
15 Aug 2023 //
GLOBENEWSWIRE
Moderna loses bid to shift liability in COVID-19 vaccine patent case
11 Mar 2023 //
REUTERS
U.S. backs Moderna, says government should face COVID-19 vaccine lawsuit
15 Feb 2023 //
REUTERS
Moderna`s motion to dismiss patent suit denied by federal judge
04 Nov 2022 //
FIERCEPHARMA
Moderna hits back in one of several COVID vaccine patent suits
11 May 2022 //
FIERCEPHARMA
Pfizer partner sues to defend COVID-19 shot Comirnaty
23 Mar 2022 //
FIERCEPHARMA
Arbutus Bio & Genevant Sciences File Patent Infringement Lawsuit Against Moderna
28 Feb 2022 //
GLOBENEWSWIRE
Takeda inks another biobucks pact: $900M for Immusoft`s B cells
14 Oct 2021 //
FIERCEBIOTECH
Poseida, Takeda ink $3.6B pact for 8 non-viral gene therapies
13 Oct 2021 //
FIERCEBIOTECH
Genevant Sciences Announces Collaboration and License Agreement with Takeda
23 Aug 2021 //
BUSINESSWIRE
Genevant scores with Takeda as LNPs continue to attract interest for RNA therapy
23 Aug 2021 //
ENDPTS
Genevant Sciences Announces Global Collaboration and License Agreement
15 Mar 2021 //
BUSINESSWIRE
JPM recap: Must-reads of the week, from FDA to IPO to M&A
12 Jan 2019 //
FIERCE PHARMA
Roivant brings Pfizer vets Azoulay, Gulfo into its C-suite
19 May 2018 //
ENDPTS
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.